RudaCure has been selected for 仁川 City's 研发 Activation Project '研发 Planning Consulting Support Project' for consulting on RCI002 (疼痛治疗药).
Through this selection, the company will receive consulting support for the commercialization and IP protection of 疼痛治疗药 RCI002 — currently in preparation for PCT and 美国 专利申请s — as well as IP portfolio construction. This will serve as the basis for establishing its 研发 strategy.